The customer concentration you didn't name on the deck

At one company, a single logo carried 42% of annual revenue. The deck called the revenue base enterprise customers, with an s, in a sentence built to imply plurality without naming a number. The next slide showed ARR climbing on a clean quarterly line, with no concentration breakout anywhere on the page. The logo grid gave the dominant customer the same visual weight as a client worth under fifty thousand a year.

The investor asked in minute fifteen. What percentage of revenue is your top customer? The founder paused, weighed it, and said the number. The room cooled. The next twenty minutes of questions got sharper. The deal didn't close.

Customer concentration is the most reliable diligence question in B2B fundraising. Every serious investor asks it. Every serious investor knows it's hidden more often than declared. Hiding doesn't work, because the number is recoverable from any of three places: the cohort chart, the AR aging, the reference list. The investor reconstructs it if you won't. All the hiding buys you is a signal, that you didn't understand the question or hoped it wouldn't come. Both read badly. The second reads worse, because it says you'll obscure material facts when it's convenient.

The slide that works is uncomfortable to write and far stronger to present. Customer A is forty-two percent of ARR. Three-year contract, two years left. Embedded across these workflows. Our plan takes it to twenty-five percent by Q4 through these three named cohorts. The number is bigger and the math is harder, and you walk into the next half hour with more credibility than a stack of padded cohort charts would ever buy you.

Most founders can't write that slide, because they haven't done the diversification work. The forty-two percent is a present fact and an empty future. The slide can't exist until the work does. So the slide forces the work. That's its real job: not communication, discipline. The founder who leaves concentration out of the deck is the same one who left diversification out of the operating plan, right up until the big customer renewed at a discount or walked. Your best margin can quietly become your [worst customer](/blog/most-profitable-product-quietly-eating/), and concentration is how that happens.

The customer who knows they're forty-two percent of your revenue renegotiates harder every renewal. They know. Procurement teams back into the figure from your funding announcements and headcount. The math isn't hidden. A customer with that leverage spends it slowly: a price concession at the first renewal, services bundled in without an ARR bump, a custom integration you build at your own cost. Each concession is small. The stack of them isn't. In effect they're capturing the pricing power you'd otherwise hold, the same way an unowned [cash collection cycle](/blog/cash-collection-nobody-owned/) quietly bleeds the balance sheet.

The leverage exists whether or not you name it. Naming it on the deck doesn't create the risk. It shows you can see it. The investor wants two things: proof you understand your structural risks, and proof you're reducing them. The concentration slide answers both in two sentences each. The buried version answers neither, and adds that you're either unaware or evasive.

The diversification plan is the harder half, and the part that moves the term sheet. We'll cut concentration to twenty-five percent by Q4 is the easy version. The hard version names the cohorts that produce the diversification, the ARR each one carries, the channel behind each, and the date on every milestone. The hard version is specific enough that the investor can stress-test it. How much confidence survives that test decides whether your concentration reads as a managed risk or an unfixed one.

Founders default to the easy version because the hard one needs the work to already exist. A deck can't outrun the operating reality. The founder who writes the hard version has run the cohort analysis, picked the three segments, and put the GTM team on the milestones. The one who hasn't can't write it honestly, and the easy version reads as the wish it is.

Concentration is one of the few company risks you can't fix faster than operations allow. Diversification needs cohorts of new customers, which need pipeline, which need quarters of sales and marketing to build. Discover three weeks before a raise that concentration will be the meeting's center of gravity, and you can't diversify in three weeks. You present it honestly with the work underway, or you delay the raise until the work has produced. Timing the round against the work is its own [decision worth getting right](/blog/best-time-raise-capital-strong-team-product-feedback/).

Most founders do neither. They obscure, hope, and learn in the room that obscuring failed. The cost is the round that doesn't close, or closes lower, or closes on terms priced to the risk they wouldn't name.

Lead with the number. Lead with the plan. The founder who states the concentration in two sentences and the diversification in three gets the term sheet. The one who buries it gets the polite pass.

Before your next investor meeting, ask:

• What's our customer concentration, named precisely, including anyone above ten percent of ARR?
• What's the diversification plan, with named cohorts, ARR targets, and dated milestones?
• Will the plan cut concentration meaningfully before the investor's next diligence cycle?
• If concentration surfaces in minute fifteen, can I cover the number and the plan in two paragraphs each?

Say the number first, and it's a conversation. Let the investor pull it out of you, and it's a verdict.